Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORIMUNO-COAG: Therapeutic Anticoagulation in COVID-19
NCT04344756Phase 2Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2020
- Primary completion
- Jul 2020
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tinzaparin, heparin in COVID-19 pneumonia, sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
tinzaparinheparin
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04344756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04344756.